Cascade Investment, L.L.C. - Sep 16, 2021 Form 3 Insider Report for Ginkgo Bioworks Holdings, Inc. (DNA)

Role: 10%+ Owner
Signature: Cascade Investment, L.L.C. By: /s/ Alan Heuberger, Attorney-in-fact for Michael Larson, Business Manager
Stock symbol: DNA
Transactions as of: Sep 16, 2021
Transactions value $: $0
Form type: 3
Date filed: 9/24/2021, 04:24 PM
Previous filing: Aug 6, 2021
Next filing: Sep 28, 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	DNA	Class A Common Stock						152M	Sep 16, 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 15,949,483 earn-out shares that will vest in four substantially equal installments if the issuer's Class A Common Stock achieves a price per share for any period of 20 trading days out of 30 consecutive trading days prior to September 16, 2026 that equals or exceeds the following thresholds: $12.50, $15.00, $17.50 and $20.00.

Remarks:

Exhibit List: Exhibit 24.1 - Power of Attorney (Cascade Investment, L.L.C.); Exhibit 24.2 - Power of Attorney (William H. Gates III)